NOV 26, 2016 3:19 PM PST

Cytoplasmic Droplet Formation is Related to Protein Regulation

WRITTEN BY: Carmen Leitch
First detected by Santiago Ramón y Cajal, there are strange droplets in the cytoplasm of cells that are not well understood. They are clumps of proteins that are amorphous, with no apparent structure and no membrane. There has been considerable interest in them lately, as they seem to be important to the activities and functions of the cell. They have also been linked to several diseases.
 
CPEB4 liquid-like droplets in the cell cytoplasm / Credit: J. Guillén-Boixet, IRB Barcelona
 
New work published in the journal eLife and led by Raúl Méndez and Xavier Salvatella, both researchers at the Institute for Research in Biomedicine in Barcelona (IRB), describes one example of the regulation and dynamics of these interesting protein aggregates. They have outlined how the protein clumps in this case make up an RNA binding protein called CPEB4.
 
CPEB4 is one of a family of proteins that are involved in many cell functions and have been associated with neurodegenerative diseases and cancer. CPEB4 seems to also function to activate or repress whether messenger RNA (mRNA) is translated into a protein by the cell – cells use messenger RNA as tool to copy genes from the genome so the cell can use its machinery to translate that copy into a protein. CPEB4 contains some sections that lack structure, remaining unfolded and flexible so that droplets can be both created and regulated during the cell cycle.
 
Previous work by these investigators demonstrated that CPEB4 controls the timeline of how cell division regulators are expressed. Jordina Guillén-Boixet, a postdoctoral fellow in Méndez's lab who is soon to continue work on these droplets in a lab at Max Planck in Germany, has spent seven years on the mechanics of CPEB4.
 
Guillén-Boixet found that CPEB4 proteins use their freeform parts to recognize one another, binding together to make the droplets. That sequesters mRNAs, keeping them from ribosomes, thus preventing protein translation. The characteristics of this aggregation allows for easy reversal when it’s the right time to translate RNA into proteins.
 

 
The research team has now determined exactly how the CPEB4 droplets form and break up during the cell cycle. They’ve also found the enzymes that phosphorylate various proteins needed to break down the aggregates and release the mRNAs. In the video above fro the new publication, live-imaging of a cell transfected with a GFP-tagged CPEB4 construct shows two liquid-like droplets fusing.
 
The researchers think that this research strengthens the veracity of two lines of thinking associated with the droplets. One is that the most RNA-binding proteins likely form these droplet organelles.
 
"[These organelles] were previously thought to be dispersed in the cytoplasm," explained Méndez. “This is the first study that characterizes how this process is regulated during the cell cycle for a protein that binds and regulates the translation of a family of mRNAs, and it paves the way for testing other families," he added.
 
The other idea is that only proteins with disordered regions can make such droplets. The majority of human proteins do have regions of disorder. "Evolution has selected disordered regions probably because they confer dynamics and versatility to proteins--greater speed to assemble and disassemble interactions--which is advantageous for signaling," explained Xavier Salvatella, a molecular biophysics and disordered proteins specialist at IRB Barcelona.
 
"These proteins are not freely floating around the cytoplasm but group in a certain way to form compartments, in a kind of order that enables them to perform cell functions. This is why the increasingly more precise description of these membrane-less organelles is so important in biology," the researchers added. Continuing work focuses on how these droplets contribute to disease states.
 
Sources: AAAS/Eurekalert! via IRB eLife
About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 12, 2021
Microbiology
Revealing the Efficient Enzymes of Methane-Producing Microbes
OCT 12, 2021
Revealing the Efficient Enzymes of Methane-Producing Microbes
The atmospheric levels of methane, which is known to be a potent greenhouse gas, have been steadily increasing for many ...
NOV 08, 2021
Clinical & Molecular DX
Sample Prep Possibilities: How to Gauge Your "Good Enough"
NOV 08, 2021
Sample Prep Possibilities: How to Gauge Your "Good Enough"
As scientists, we can be very uncomfortable with the concept of “good enough”. It feels contrary to everythi ...
OCT 28, 2021
Cell & Molecular Biology
The Production & Export of Ribosomal Subunits is Caught on Video
OCT 28, 2021
The Production & Export of Ribosomal Subunits is Caught on Video
Protein production is essential for life; cells use DNA to transcribe active genes into RNA sequences, and ribosomes tra ...
NOV 01, 2021
Cell & Molecular Biology
How SARS-CoV-2 Evades Antiviral Defenses
NOV 01, 2021
How SARS-CoV-2 Evades Antiviral Defenses
Researchers have learned a lot about the SARS-CoV-2 virus since the start of the COVID-19 pandemic. We know that he viru ...
NOV 14, 2021
Genetics & Genomics
Cancer Drug Target Could Actually Worsen Disease
NOV 14, 2021
Cancer Drug Target Could Actually Worsen Disease
Cancer drugs have been developed that target an enzyme, Shp2. But that enzyme has a more complex role than we knew.
NOV 21, 2021
Microbiology
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
NOV 21, 2021
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
Zoonosis is a serious health concern, as the COVID-19 pandemic has shown. Viruses that infect one species can acquire ge ...
Loading Comments...